Alnylam Pharma Stock Price (NASDAQ:ALNY)

Add to My Stocks
$46.62 $0.37 (0.8%) ALNY stock closing price Feb 24, 2017 (Closing)
Alnylam Pharma
24 FEB 2017
amigobulls logo
ALNY hand_up
ALNY vs S&P 500
Closing Price: Feb 24, 2017
$46.62 ( 0.8%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: -18.66%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Alnylam Pharma Snapshot Video

13 5 2

ALNY Stock Details

Prev Close* : $46.25
Market Cap:
Day Low: $45
52 Week Low: $31.38
Open: $45.9
Volume: 642690
Day High: $47.15
52 Week High: $80.11

Latest Stock Market News

Latest Articles

Alnylam Pharma News - From Partners

ALNY Stockcharts

View ALNY PE ratio, PS ratio stocks charts and compare with peers.
ALNY Chart
Note: Compare Alnylam Pharma stock price history with the index and industry peers.

Alnylam Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Alnylam Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

ALNY Industry Peers

Company Price Change (%)
Bioverativ Inc (BIVV)50.961.4 (2.82%)
Acadia Pharma (ACAD)38.880.68 (1.72%)
Arrowhead Pharma (ARWR)2.150.03 (1.42%)
Regulus Therapeutics (RGLS)1.10.05 (4.76%)
Benitec Biopharma (BNTC)2.470.06 (2.37%)
Sanofi (SNY)42.70.19 (0.45%)
Takeda Pharma (TKPYY)23.810.13 (0.55%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

Alnylam Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues41.09M50.56M47.16M66.72M82.75M
Net Income-290.07M-360.39M-89.22M-106.01M-57.64M
Total Operating Expense337.1M455.53M140.1M196.17M137.57M
view Alnylam Pharmaceuticals, Inc. income statement
balance sheet20152014201320122011
Total Assets1.39B1.08B420.53M287.52M281.91M
Total Liabilities121.79M143.32M150.18M153.46M163.92M
Shareholders Equity1.26B936.26M270.34M134.05M117.99M
view Alnylam Pharmaceuticals, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities35.11M-29.4M-8.11M-8.96M-55.92M
Net Cash From (Used By) Operating Activities-189.14M-165.64M-68.65M-115.6M-87.06M
Increase (Decrease) In Prop Plant And Equipment-12.95M-8.96M-4M-8.34M-1.29M
view Alnylam Pharmaceuticals, Inc. cashflow statement

Alnylam Pharmaceuticals, Inc. Stock News - Partner Headlines

Alnylam Pharma Stock Message Board

An investor needs to spend 46.62 to buy ALNY stock, as the closing Alnylam Pharma stock price is 46.62. Alnylam Pharma market capitalization is 3.98B and it represents the total market value of ALNY stock. Alnylam Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Alnylam Pharma is worth a lot, it will most likely be reflected in an inflated Alnylam Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 642690 ALNY shares were traded yesterday, and Alnylam Pharma stock chart shows that the ALNY stock quote hit a day high of 47.15 and day low of 45. One can observe stock price trends and check for volatility by checking Alnylam Pharma stock price history.